is is an oral prescription medication to treat obesity. It woks on the principle of blocking the CB-1 receptors situated in the Endo-cannabinoid system. Consumption of Acomplia primarily blocks the functioning of these receptors, resulting in a decrease of your normal appetite. A reduced appetite means that you would eat less, and in turn loose weight.

Combining a proper diet and workout plan along with Acomplia (Rimonabant) can fetch you optimistic weight loss results. 20mg is the customary dosage which is recommended by doctors for usage. A before-hand consultation with your doctor is required before you commence upon Acomplia (Rimonabant) medication. Never overindulge in usage of Acomplia, as it may be detrimental to your health. Stick your doctors' advice.

Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi-Aventis is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with and Tobacco Use Program involved more than 6,000 subjects. The programme is designed to explore two smoking-related therapies.

On 21 June 2006, the European Commission approved the sale of Acomplia in the then 25-member European Union. This amazing weight loss drug has already been made saleable in a lot of European countries. The EU's approval was not a blanket approval, nor did it approve Acomplia for non-obesity related problems such as smoking cessation, although off-label use of the drug is still possible. The approval is in combination with diet and exercise for the treatment of obese patients. You can buy Acomplia (Rimonabant), through a choice of online pharmacies and street retailers.